Undergoing a bone marrow transplant during adolescence, but not in adulthood, may lower the risk of stroke with SCD, a mouse ...
When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...
Esther Nkemakolam runs her fingers through kinetic sand and sings a “Moana” song as UPMC Children’s Hospital nurse Taylor ...
The more weight people with type 2 diabetes lose, the greater the odds that the disease will go partially or even completely ...
A new stem cell transplant type was effective for most patients in a clinical trial, pointing to its use as a potential ...
A new type of bone marrow transplant can cure sickle cell disease with only half of the donor's cell proteins matching, ...
A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...
A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers.
Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...
A person can be a carrier of the gene for sickle cell anemia without being sick. Carriers do not have a higher risk of developing the disease than other people. However, the gene for the disease can ...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback